Clinical Quality Indicators in Inflammatory Bowel Disease

Clinical Quality Indicators in Inflammatory Bowel Disease

Saved in:

Bibliographic Details
Main Author:	Subrata Ghosh
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2014/270407
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in Inflammatory Bowel Disease: Are Patients Taking Their Medicines?
by: Subrata Ghosh, et al.
Published: (2009-01-01)

Should We Establish Standards of Care for Management of Elderly Patients with Inflammatory Bowel Disease?
by: Subrata Ghosh, et al.
Published: (2015-01-01)

Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again?
by: Marietta Iacucci, et al.
Published: (2010-01-01)

Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada
by: Geoffrey C Nguyen, et al.
Published: (2014-01-01)

Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease
by: Lik Hang Lee, et al.
Published: (2017-01-01)

Management of the Pregnant Inflammatory Bowel Disease Patient on Antitumour Necrosis Factor Therapy: State of the Art and Future Directions
by: Yvette PY Leung, et al.
Published: (2014-01-01)

A Quality of Life Index for Inflammatory Bowel Disease
by: E Jan Irvine
Published: (1993-01-01)

Dysplasia in Inflammatory Bowel Diseases: Definition and Clinical Impact
by: Karel Geboes, et al.
Published: (1999-01-01)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01)

Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01)

Autoimmunity in Inflammatory Bowel Disease
by: Kiron M Das
Published: (1993-01-01)

Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997-01-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01)

Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
by: Panu Wetwittayakhlang, et al.
Published: (2021-01-01)

Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Ingvar Bjarnason, et al.
Published: (1993-01-01)

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease
by: Yao Wei, et al.
Published: (2015-01-01)

Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Treatment of Inflammatory Bowel Disease in Children
by: D Grant Gall
Published: (1990-01-01)

Trends in Inflammatory Bowel Disease Therapy
by: L Sutherland, et al.
Published: (1990-01-01)

Osteomyelitis and Osteonecrosis in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (1997-01-01)

The Changing Phenotype of Inflammatory Bowel Disease
by: Carthage Moran, et al.
Published: (2016-01-01)

Thromboelastography in Patients with Inflammatory Bowel Disease
by: Yonghua Shen, et al.
Published: (2020-01-01)

Ocular Complications of Inflammatory Bowel Disease
by: Rana Mady, et al.
Published: (2015-01-01)

Cancer Risk in Inflammatory Bowel Disease
by: Anders M Ekbom
Published: (1995-01-01)

Review of Inflammatory Bowel Disease in China
by: Lingna Ye, et al.
Published: (2013-01-01)

T Cell Repertoire and Inflammatory Bowel Disease
by: Kenneth Croitoru, et al.
Published: (1996-01-01)

The Influence of Nutrients on Inflammatory Bowel Diseases
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2020-01-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review
by: C.N. Williams
Published: (1987-01-01)

Novel Targets for Anti-Inflammatory Therapy in Inflammatory Bowel Disease
by: John L Wallace
Published: (1994-01-01)

Inflammatory Mediators in Inflammatory Bowel Disease: Clues for Designer Therapy
by: John L Wallace
Published: (1993-01-01)

Quality improvement exercises in Inflammatory Bowel Disease (IBD) services: A scoping review.
by: Katie Ridsdale, et al.
Published: (2024-01-01)

Does the Level of Reproductive Knowledge Specific to Inflammatory Bowel Disease Predict Childlessness among Women with Inflammatory Bowel Disease?
by: Vivian W Huang, et al.
Published: (2015-01-01)

The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases
by: Cheryl Kluthe, et al.
Published: (2018-01-01)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
by: Esmail Abej, et al.
Published: (2016-01-01)

Evaluation of the Clinical Efficacy of Prednisolone in the Treatment of Inflammatory Bowel Diseases with Different Dosage Methods
by: O. P. Alekseeva, et al.
Published: (2023-05-01)